These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 23871637)

  • 41. miR-23a-3p is a Key Regulator of IL-17C-Induced Tumor Angiogenesis in Colorectal Cancer.
    Lee Y; Kim SJ; Choo J; Heo G; Yoo JW; Jung Y; Rhee SH; Im E
    Cells; 2020 Jun; 9(6):. PubMed ID: 32492770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation.
    Quan L; Ohgaki R; Hara S; Okuda S; Wei L; Okanishi H; Nagamori S; Endou H; Kanai Y
    J Exp Clin Cancer Res; 2020 Nov; 39(1):266. PubMed ID: 33256804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapy.
    Agarwal A; Tressel SL; Kaimal R; Balla M; Lam FH; Covic L; Kuliopulos A
    Cancer Res; 2010 Jul; 70(14):5880-90. PubMed ID: 20570895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The vascular delta-like ligand-4 (DLL4)-Notch4 signaling correlates with angiogenesis in primary glioblastoma: an immunohistochemical study.
    Zhang JF; Chen Y; Qiu XX; Tang WL; Zhang JD; Huang JH; Lin GS; Wang XF; Lin ZX
    Tumour Biol; 2016 Mar; 37(3):3797-805. PubMed ID: 26472724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor.
    Soto-Pantoja DR; Menon J; Gallagher PE; Tallant EA
    Mol Cancer Ther; 2009 Jun; 8(6):1676-83. PubMed ID: 19509262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting non-canonical nuclear factor-κB signalling attenuates neovascularization in a novel 3D model of rheumatoid arthritis synovial angiogenesis.
    Maracle CX; Kucharzewska P; Helder B; van der Horst C; Correa de Sampaio P; Noort AR; van Zoest K; Griffioen AW; Olsson H; Tas SW
    Rheumatology (Oxford); 2017 Feb; 56(2):294-302. PubMed ID: 27864565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycosylation controls cooperative PECAM-VEGFR2-β3 integrin functions at the endothelial surface for tumor angiogenesis.
    Imamaki R; Ogawa K; Kizuka Y; Komi Y; Kojima S; Kotani N; Honke K; Honda T; Taniguchi N; Kitazume S
    Oncogene; 2018 Aug; 37(31):4287-4299. PubMed ID: 29717262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of the transcriptional repressor complex Bcl-6/BCoR induces endothelial sprouting but does not promote tumor growth.
    Buchberger E; Payrhuber D; El Harchi M; Zagrapan B; Scheuba K; Zommer A; Bugyik E; Dome B; Kral JB; Schrottmaier WC; Schabbauer G; Petzelbauer P; Gröger M; Bilban M; Brostjan C
    Oncotarget; 2017 Jan; 8(1):552-564. PubMed ID: 27880939
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single-Cell Transcriptome Analyses Reveal Endothelial Cell Heterogeneity in Tumors and Changes following Antiangiogenic Treatment.
    Zhao Q; Eichten A; Parveen A; Adler C; Huang Y; Wang W; Ding Y; Adler A; Nevins T; Ni M; Wei Y; Thurston G
    Cancer Res; 2018 May; 78(9):2370-2382. PubMed ID: 29449267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ADGRL4/ELTD1 Silencing in Endothelial Cells Induces ACLY and SLC25A1 and Alters the Cellular Metabolic Profile.
    Favara DM; Zois CE; Haider S; Pires E; Sheldon H; McCullagh J; Banham AH; Harris AL
    Metabolites; 2019 Nov; 9(12):. PubMed ID: 31775252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth.
    Liu H; Qiu Y; Pei X; Chitteti R; Steiner R; Zhang S; Jin ZG
    Sci Rep; 2020 Nov; 10(1):20493. PubMed ID: 33235311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
    Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C
    Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting prion-like protein doppel selectively suppresses tumor angiogenesis.
    Al-Hilal TA; Chung SW; Choi JU; Alam F; Park J; Kim SW; Kim SY; Ahsan F; Kim IS; Byun Y
    J Clin Invest; 2016 Apr; 126(4):1251-66. PubMed ID: 26950422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endothelin-1 promotes vascular endothelial growth factor-dependent angiogenesis in human chondrosarcoma cells.
    Wu MH; Huang CY; Lin JA; Wang SW; Peng CY; Cheng HC; Tang CH
    Oncogene; 2014 Mar; 33(13):1725-35. PubMed ID: 23584483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Notch pathway targets proangiogenic regulator Sox17 to restrict angiogenesis.
    Lee SH; Lee S; Yang H; Song S; Kim K; Saunders TL; Yoon JK; Koh GY; Kim I
    Circ Res; 2014 Jul; 115(2):215-26. PubMed ID: 24755984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis.
    Noguera-Troise I; Daly C; Papadopoulos NJ; Coetzee S; Boland P; Gale NW; Lin HC; Yancopoulos GD; Thurston G
    Nature; 2006 Dec; 444(7122):1032-7. PubMed ID: 17183313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IGF binding protein-6 expression in vascular endothelial cells is induced by hypoxia and plays a negative role in tumor angiogenesis.
    Zhang C; Lu L; Li Y; Wang X; Zhou J; Liu Y; Fu P; Gallicchio MA; Bach LA; Duan C
    Int J Cancer; 2012 May; 130(9):2003-12. PubMed ID: 21618524
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of tumor angiogenesis and tumor growth by the DSL domain of human Delta-like 1 targeted to vascular endothelial cells.
    Zhao XC; Dou GR; Wang L; Liang L; Tian DM; Cao XL; Qin HY; Wang CM; Zhang P; Han H
    Neoplasia; 2013 Jul; 15(7):815-25. PubMed ID: 23814493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.
    Li JL; Sainson RC; Shi W; Leek R; Harrington LS; Preusser M; Biswas S; Turley H; Heikamp E; Hainfellner JA; Harris AL
    Cancer Res; 2007 Dec; 67(23):11244-53. PubMed ID: 18056450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cdc42-mediated inhibition of GSK-3β improves angio-architecture and lumen formation during VEGF-driven pathological angiogenesis.
    Hoang MV; Nagy JA; Senger DR
    Microvasc Res; 2011 Jan; 81(1):34-43. PubMed ID: 20849862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.